Spring Creek Capital, McCoy Enterprises Enter Into Licensing Agreement For Debride WH-1
The Debride WH-1 topical treatment product was developed by McCoy Enterprises, the same organisation responsible for creation of the buccal mucosa drug delivery system licensed to Spring Creek
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.